NCT01530607: Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer |
|
|
| Completed | 3 | 416 | US, RoW | Standard cyclophosphamide, Goserelin (Zoladex) | King Faisal Specialist Hospital & Research Center | Breast Cancer | 11/12 | 11/12 | | |
CRUK-OPTION, NCT00427245: Goserelin in Preventing Early Menopause in Premenopausal Women Undergoing Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer |
|
|
| Completed | 3 | 400 | Europe | cyclophosphamide, goserelin acetate, adjuvant therapy, fertility assessment and management, neoadjuvant therapy | Anglo Celtic Cooperative Oncology Group | Breast Cancer, Infertility, Menopausal Symptoms | | | | |
